Geovax Labs Stock Analysis
| GOVX Stock | USD 1.52 0.06 4.11% |
GeoVax Labs is undervalued with Real Value of 2.62 and Target Price of 6.0. The main objective of GeoVax Labs stock analysis is to determine its intrinsic value, which is an estimate of what GeoVax Labs is worth, separate from its market price. There are two main types of GeoVax Labs' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect GeoVax Labs' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of GeoVax Labs' stock to identify patterns and trends that may indicate its future price movements.
The GeoVax Labs stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. GeoVax Labs is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. GeoVax Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and GeoVax Labs' ongoing operational relationships across important fundamental and technical indicators.
GeoVax |
GeoVax Stock Analysis Notes
About 15.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. GeoVax Labs recorded a loss per share of 14.29. The entity last dividend was issued on the 25th of September 2020. The firm had 1:15 split on the 31st of January 2024. GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia. Geovax Labs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people. To learn more about GeoVax Labs call Robert McNally at 678 384 7220 or check out https://www.geovax.com.GeoVax Labs Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. GeoVax Labs' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding GeoVax Labs or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| GeoVax Labs generated a negative expected return over the last 90 days | |
| GeoVax Labs has high historical volatility and very poor performance | |
| GeoVax Labs may become a speculative penny stock | |
| GeoVax Labs has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (25.97 M) with profit before overhead, payroll, taxes, and interest of 81.53 K. | |
| GeoVax Labs currently holds about 30.9 M in cash with (25.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25. | |
| GeoVax Labs has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: GeoVax Labs Stock Price Down 4.8 percent - Defense World |
GeoVax Labs Upcoming and Recent Events
Earnings reports are used by GeoVax Labs to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to GeoVax Labs previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
GeoVax Largest EPS Surprises
Earnings surprises can significantly impact GeoVax Labs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-05-04 | 2023-03-31 | -0.2 | -0.15 | 0.05 | 25 | ||
2022-11-09 | 2022-09-30 | -0.12 | -0.17 | -0.05 | 41 | ||
2023-08-09 | 2023-06-30 | -0.16 | -0.22 | -0.06 | 37 |
GeoVax Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as GeoVax Labs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GeoVax Labs backward and forwards among themselves. GeoVax Labs' institutional investor refers to the entity that pools money to purchase GeoVax Labs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2023-09-30 | 32.0 | Ubs Group Ag | 2023-12-31 | 0.0 | Gsa Capital Partners Llp | 2023-09-30 | 0.0 | Virtu Financial Llc | 2023-09-30 | 0.0 | Advisor Group Holdings, Inc. | 2023-12-31 | 0.0 | Two Sigma Securities, Llc | 2023-09-30 | 0.0 | Vanguard Group Inc | 2023-09-30 | 728.4 K | Blackrock Inc | 2023-09-30 | 413.4 K | Geode Capital Management, Llc | 2023-09-30 | 172.9 K | State Street Corporation | 2023-09-30 | 97.9 K | Morgan Stanley - Brokerage Accounts | 2023-09-30 | 50.2 K |
GeoVax Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GeoVax Labs's market, we take the total number of its shares issued and multiply it by GeoVax Labs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.GeoVax Profitablity
GeoVax Labs' profitability indicators refer to fundamental financial ratios that showcase GeoVax Labs' ability to generate income relative to its revenue or operating costs. If, let's say, GeoVax Labs is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, GeoVax Labs' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of GeoVax Labs' profitability requires more research than a typical breakdown of GeoVax Labs' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.80) | (2.94) | |
| Return On Capital Employed | (4.64) | (4.41) | |
| Return On Assets | (2.80) | (2.94) | |
| Return On Equity | (4.51) | (4.28) |
Management Efficiency
GeoVax Labs has return on total asset (ROA) of (0.8227) % which means that it has lost $0.8227 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6047) %, meaning that it created substantial loss on money invested by shareholders. GeoVax Labs' management efficiency ratios could be used to measure how well GeoVax Labs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.94 in 2024. Return On Capital Employed is likely to rise to -4.41 in 2024. At this time, GeoVax Labs' Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.2 M in 2024, whereas Total Assets are likely to drop slightly above 4.9 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.17 | 3.33 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 3.17 | 3.33 | |
| Enterprise Value Over EBITDA | (0.13) | (0.13) | |
| Price Book Value Ratio | 1.71 | 1.62 | |
| Enterprise Value Multiple | (0.13) | (0.13) | |
| Price Fair Value | 1.71 | 1.62 | |
| Enterprise Value | 3.4 M | 3.6 M |
The analysis of GeoVax Labs' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze GeoVax Labs' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of GeoVax Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 2.917 |
Technical Drivers
As of the 19th of April, GeoVax Labs retains the Standard Deviation of 5.09, risk adjusted performance of (0.19), and Market Risk Adjusted Performance of (0.86). GeoVax Labs technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for GeoVax Labs, which can be compared to its competitors. Please check out GeoVax Labs information ratio and kurtosis to decide if GeoVax Labs is priced fairly, providing market reflects its last-minute price of 1.52 per share. Please also validate GeoVax Labs jensen alpha, which is currently at (1.77) to confirm the company can sustain itself at a future point.GeoVax Labs Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. GeoVax Labs middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for GeoVax Labs. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
GeoVax Labs Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GeoVax Labs insiders, such as employees or executives, is commonly permitted as long as it does not rely on GeoVax Labs' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GeoVax Labs insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mark Reynolds over two months ago Purchase by Mark Reynolds of 2000 shares of GeoVax Labs | ||
Mark Reynolds over six months ago Purchase by Mark Reynolds of 10000 shares of GeoVax Labs | ||
Mark Reynolds over six months ago Acquisition by Mark Reynolds of 100000 shares of GeoVax Labs subject to Rule 16b-3 | ||
Mark Reynolds over six months ago Purchase by Mark Reynolds of 8000 shares of GeoVax Labs |
GeoVax Labs Predictive Daily Indicators
GeoVax Labs intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GeoVax Labs stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
GeoVax Labs Forecast Models
GeoVax Labs' time-series forecasting models are one of many GeoVax Labs' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GeoVax Labs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About GeoVax Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how GeoVax Labs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling GeoVax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as GeoVax Labs. By using and applying GeoVax Stock analysis, traders can create a robust methodology for identifying GeoVax entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (155.80) | (148.01) | |
| Operating Profit Margin | (199.18) | (189.22) | |
| Net Loss | (198.97) | (189.02) | |
| Gross Profit Margin | 0.35 | 0.37 |
Current GeoVax Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. GeoVax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. GeoVax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 6.0 | Strong Buy | 2 | Odds |
Most GeoVax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand GeoVax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of GeoVax Labs, talking to its executives and customers, or listening to GeoVax conference calls.
GeoVax Stock Analysis Indicators
GeoVax Labs stock analysis indicators help investors evaluate how GeoVax Labs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading GeoVax Labs shares will generate the highest return on investment. By understating and applying GeoVax Labs stock analysis, traders can identify GeoVax Labs position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 27.6 M | |
| Common Stock Shares Outstanding | 1.8 M | |
| Total Stockholder Equity | 5.8 M | |
| Property Plant And Equipment Net | 209.7 K | |
| Cash And Short Term Investments | 6.5 M | |
| Cash | 6.5 M | |
| Accounts Payable | 2.8 M | |
| Net Debt | -6.5 M | |
| 50 Day M A | 2.1098 | |
| Total Current Liabilities | 3.5 M | |
| Other Operating Expenses | 26.7 M | |
| Non Current Assets Total | 1.4 M | |
| Forward Price Earnings | 10.627 | |
| Non Currrent Assets Other | 1.2 M | |
| Stock Based Compensation | 1.1 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GeoVax Labs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for GeoVax Stock analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is GeoVax Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GeoVax Labs. If investors know GeoVax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GeoVax Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.29) | Quarterly Revenue Growth (1.00) | Return On Assets (0.82) | Return On Equity (1.60) |
The market value of GeoVax Labs is measured differently than its book value, which is the value of GeoVax that is recorded on the company's balance sheet. Investors also form their own opinion of GeoVax Labs' value that differs from its market value or its book value, called intrinsic value, which is GeoVax Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GeoVax Labs' market value can be influenced by many factors that don't directly affect GeoVax Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GeoVax Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if GeoVax Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GeoVax Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.